TY - JOUR
T1 - Stimulation of autophagy by the p53 target gene Sestrin2
AU - Maiuri, Maria Chiara
AU - Malik, Shoaib Ahmad
AU - Morselli, Eugenia
AU - Kepp, Oliver
AU - Criollo, Alfredo
AU - Mouchel, Pierre Luc
AU - Carnuccio, Rosa
AU - Kroemer, Guido
N1 - Funding Information:
We thank Dr. B. Vogelstein (John Hopkins University, Bethesda, MA) for p53 knockout cells, Dr. C.G. Maki (Department of Radiation and Cellular Oncology, University of Chicago, IL) for p53 plasmids, Dr. Amena Ben Younes and Dr. Ilio Vitale for expert assistance. S.A.M. is a recipient of the HEC (Higher Education Commission of Pakistan) Overseas Scholarship Program 2008. E.M. is a recipient of a Ph.D fellowship from ApopTrain (Marie Curie network of the European Union). O.K. is a recipient of an EMBO fellowship. G.K. is supported by Ligue Nationale contre le Cancer, Agence Nationale pour la Recherche, Cancéropôle Ile-de-France, INCa, Fondation pour la Recherche Médicale and European Union (Active p53, Apo-Sys, ApopTrain, ChemoRes, TransDeath, RIGHT). The authors declare no competing financial interests.
PY - 2009/5/15
Y1 - 2009/5/15
N2 - The oncosuppressor protein p53 regulates autophagy in a dual fashion. The pool of cytoplasmic p53 protein represses autophagy in a transcription- independent fashion, while the pool of nuclear p53 stimulates autophagy through the transactivation of specific genes. Here we report the discovery that Sestrin2, a novel p53 target gene, is involved in the induction of autophagy. Depletion of Sestrin2 by RNA interference reduced the level of autophagy in a panel of p53-sufficient human cancer cell lines responding to distinct autophagy inducers. In quantitative terms, Sestrin2 depletion was as efficient in preventing autophagy induction as was the depletion of Dram, another p53 target gene. Knockout of either Sestrin2 or Dram reduced autophagy elicited by nutrient depletion, rapamycin, lithium or thapsigargin. Moreover, autophagy induction by nutrient depletion or pharmacological stimuli led to an increase in Sestrin2 expression levels in p53-proficient cells. In strict contrast, the depletion of Sestrin2 or Dram failed to affect autophagy in p53-deficient cells and did not modulate the inhibition of baseline autophagy by a cytoplasmic p53 mutant that was reintroduced into p53-deficient cells. We conclude that Sestrin2 acts as a positive regulator of autophagy in p53-proficient cells.
AB - The oncosuppressor protein p53 regulates autophagy in a dual fashion. The pool of cytoplasmic p53 protein represses autophagy in a transcription- independent fashion, while the pool of nuclear p53 stimulates autophagy through the transactivation of specific genes. Here we report the discovery that Sestrin2, a novel p53 target gene, is involved in the induction of autophagy. Depletion of Sestrin2 by RNA interference reduced the level of autophagy in a panel of p53-sufficient human cancer cell lines responding to distinct autophagy inducers. In quantitative terms, Sestrin2 depletion was as efficient in preventing autophagy induction as was the depletion of Dram, another p53 target gene. Knockout of either Sestrin2 or Dram reduced autophagy elicited by nutrient depletion, rapamycin, lithium or thapsigargin. Moreover, autophagy induction by nutrient depletion or pharmacological stimuli led to an increase in Sestrin2 expression levels in p53-proficient cells. In strict contrast, the depletion of Sestrin2 or Dram failed to affect autophagy in p53-deficient cells and did not modulate the inhibition of baseline autophagy by a cytoplasmic p53 mutant that was reintroduced into p53-deficient cells. We conclude that Sestrin2 acts as a positive regulator of autophagy in p53-proficient cells.
KW - Autophagy
KW - Dram
KW - Sestrins
KW - p53
UR - http://www.scopus.com/inward/record.url?scp=66849111716&partnerID=8YFLogxK
U2 - 10.4161/cc.8.10.8498
DO - 10.4161/cc.8.10.8498
M3 - Article
C2 - 19377293
AN - SCOPUS:66849111716
SN - 1538-4101
VL - 8
SP - 1571
EP - 1576
JO - Cell Cycle
JF - Cell Cycle
IS - 10
ER -